Neupro rotigotine regulatory update

FDA approved a room-temperature stable formulation of transdermal Parkinson's disease (PD) drug Neupro rotigotine from UCB along with 2 new indications. FDA approved the original formulation of Neupro in 2007 for early PD but the product was recalled in 2008 due to crystallization on the patches. ...